Bedaquiline
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
Tuberculosis: Policies should ‘help facilitate access to life saving treatment not create barriers.’
Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug
MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people
Access to medicines: MSF demands Johnson & Johnson reduce price of lifesaving TB drug
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
Renewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai
